Wakefield, RI, United States of America

Donald L Chaloupka


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Bristol, RI (US) (2013)
  • Wakefield, RI (US) (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Donald L. Chaloupka

Introduction

Donald L. Chaloupka is a notable inventor based in Wakefield, RI (US). He has made significant contributions to the field of network systems, holding a total of 3 patents. His work primarily focuses on enhancing the reliability and efficiency of network communications.

Latest Patents

Chaloupka's latest patents include innovative systems and methods for server and switch failover in a black core network. This patent describes a black core network system that incorporates a ciphertext network, a server with a bonding module, and multiple network interfaces. The system is designed to manage link failures effectively by directing traffic through backup links when primary links fail. Another patent focuses on a method for reflecting link failures in a network that utilizes an encryptor device, ensuring seamless communication between plaintext and ciphertext networks.

Career Highlights

Chaloupka is currently employed at Raytheon Company, where he continues to develop cutting-edge technologies. His expertise in network systems has positioned him as a valuable asset in the field of telecommunications and cybersecurity.

Collaborations

Some of his notable coworkers include Dennis A. Morrison and Nicholas R. Desany, who have collaborated with him on various projects within the company.

Conclusion

Donald L. Chaloupka's contributions to network technology through his patents and work at Raytheon Company highlight his role as an influential inventor in the field. His innovative approaches to network reliability continue to shape the future of communication systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…